Minireview
British Journal of Cancer (2007) 96, 681–685. doi:10.1038/sj.bjc.6603625 www.bjcancer.com
Published online 20 February 2007
Circulating tumour-derived nucleic acids in cancer patients: potential applications as tumour markers
K C A Chan1,3 and Y M D Lo1,2,3
- 1Department of Chemical Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong Special Administrative Region, China
- 2Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong Special Administrative Region, China
- 3State Key Laboratory in Oncology in South China, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong Special Administrative Region, China
Correspondence: Professor YMD Lo, Department of Chemical Pathology, Room 38023, 1/F, Clinical Sciences Building, Prince of Wales Hospital, 30-32 Ngan Shing Street, Shatin, New Territories, Hong Kong SAR; E-mail: loym@cuhk.edu.hk
Received 17 October 2006; Revised 8 January 2007; Accepted 16 January 2007; Published online 20 February 2007.
Abstract
Tumour-associated changes have been observed in the circulating nucleic acids of cancer patients and have been proposed to be useful for the detection and monitoring of cancers. In this review, different approaches for detecting tumour-associated nucleic acids in the circulation and their potential applications as tumour markers are discussed.
Keywords:
tumour marker, plasma/serum DNA, plasma/serum RNA, circulating nucleic acids
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
RESEARCH
Journal of Cerebral Blood Flow & Metabolism Original Article
